PIP5K1A: a potential target for cancers with KRAS or TP53 mutations

  • Nat Rev Drug Discov. 2020 Jul;19(7):436. doi: 10.1038/d41573-020-00067-3.
Michael P East ,  Tuomo Laitinen ,  Christopher R M Asquith
PMID: 32332925 DOI: 10.1038/d41573-020-00067-3
Products